Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer.
World J Gastroenterol
; 29(3): 579-581, 2023 Jan 21.
Article
em En
| MEDLINE
| ID: mdl-36688025
ABSTRACT
Pancreatic cancer is a malignant tumor with poor prognosis. The treatment of pancreatic cancer depends on the tumor stage and type, and includes local treatment (surgery, radiotherapy and ablation intervention) and systemic therapy (chemotherapy, targeted therapy and immunotherapy). We read with great interest the review "Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment" published on World J Gastroenterol and intended to share some of our perspectives in pancreatic cancer treatment. This review presents the therapeutic effects of the combination of gemcitabine and targeted drugs, which gives us a deeper insight into the combination treatments for pancreatic cancer.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Pancreáticas
/
Gencitabina
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article